ASH 2018 | Is CLL chemoimmunotherapy finished?

Robin Foà, MD, of Sapienza University of Rome, Rome, Italy, gives us his take on the key chronic lymphocytic leukemia (CLL) highlights from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Prof. Foà highlights novel agents changing the treatment landscape.